Literature DB >> 16093538

Suture plication, thermal shrinkage, and sclerosing agents: effects on rat patellar tendon length and biomechanical strength.

Arun Aneja1, Spero G Karas, Paul S Weinhold, Hessam M Afshari, Laurence E Dahners.   

Abstract

BACKGROUND: Shortening or tightening of dense, collagenous tissues is often desirable in the treatment of laxity.
PURPOSE: To compare the effect of stress-protection suture, radiofrequency thermal shrinkage combined with stress-protection suture, and a 5% sodium morrhuate sclerosing injection on the length and biomechanical strength of the rat patellar tendon. HYPOTHESIS: Sclerosing agents will increase tendon mechanical strength. Thermal shrinkage combined with stress-protection suture and stress-protection suture only will cause a short-term decrease in tendon strength. All 3 methods will produce equivalent shortening of the tendon. STUDY
DESIGN: Controlled laboratory study.
METHODS: Forty-six female retired breeder rats were split into 4 groups, each receiving 1 of the 3 aforementioned treatments plus a control group that received a saline injection. After 4 weeks' survival, the length and biomechanical properties of the patellar tendons were measured and compared to the contralateral untreated tendon.
RESULTS: Rats treated with stress-protection suture had shorter tendons. Radiofrequency thermal shrinkage combined with stress-protection suture yielded tendons that were both shorter and stronger than were the untreated contralateral tendons. The sodium morrhuate-injected tendons were stronger whereas the saline-treated tendons were weaker than were their respective untreated contralateral tendons.
CONCLUSION: Surgical stress-protection suture without radiofrequency shrinkage is most effective at shortening the length of the rat patellar tendon, whereas radiofrequency thermal shrinkage combined with stress-protection suture as well as sodium morrhuate are effective at increasing the strength of rat patellar tendons. CLINICAL RELEVANCE: Judicious use of thermal shrinkage in combination with stress protection may improve ligament strength and decrease laxity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16093538     DOI: 10.1177/0363546505275492

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  12 in total

Review 1.  Prolotherapy in primary care practice.

Authors:  David Rabago; Andrew Slattengren; Aleksandra Zgierska
Journal:  Prim Care       Date:  2010-03       Impact factor: 2.907

2.  Dextrose and morrhuate sodium injections (prolotherapy) for knee osteoarthritis: a prospective open-label trial.

Authors:  David Rabago; Jeffrey J Patterson; Marlon Mundt; Aleksandra Zgierska; Luke Fortney; Jessica Grettie; Richard Kijowski
Journal:  J Altern Complement Med       Date:  2014-03-17       Impact factor: 2.579

3.  Hypertonic dextrose and morrhuate sodium injections (prolotherapy) for lateral epicondylosis (tennis elbow): results of a single-blind, pilot-level, randomized controlled trial.

Authors:  David Rabago; Ken S Lee; Michael Ryan; Amrish O Chourasia; Mary E Sesto; Aleksandra Zgierska; Rick Kijowski; Jessica Grettie; John Wilson; Daniel Miller
Journal:  Am J Phys Med Rehabil       Date:  2013-07       Impact factor: 2.159

4.  Association between disease-specific quality of life and magnetic resonance imaging outcomes in a clinical trial of prolotherapy for knee osteoarthritis.

Authors:  David Rabago; Richard Kijowski; Michael Woods; Jeffrey J Patterson; Marlon Mundt; Aleksandra Zgierska; Jessica Grettie; John Lyftogt; Luke Fortney
Journal:  Arch Phys Med Rehabil       Date:  2013-07-10       Impact factor: 3.966

5.  Repair of a complete anterior cruciate tear using prolotherapy: a case report.

Authors:  Walter Grote; Rosa Delucia; Robert Waxman; Aleksandra Zgierska; John Wilson; David Rabago
Journal:  Int Musculoskelet Med       Date:  2009-12-01

6.  The efficacy of prolotherapy for lateral epicondylosis: a pilot study.

Authors:  Michael Scarpone; David P Rabago; Aleksandra Zgierska; Gennie Arbogast; Edward Snell
Journal:  Clin J Sport Med       Date:  2008-05       Impact factor: 3.638

7.  Response of knee ligaments to prolotherapy in a rat injury model.

Authors:  Kristina T Jensen; David P Rabago; Thomas M Best; Jeffrey J Patterson; Ray Vanderby
Journal:  Am J Sports Med       Date:  2008-02-29       Impact factor: 6.202

8.  Early inflammatory response of knee ligaments to prolotherapy in a rat model.

Authors:  Kristina T Jensen; David P Rabago; Thomas M Best; Jeffrey J Patterson; Ray Vanderby
Journal:  J Orthop Res       Date:  2008-06       Impact factor: 3.494

Review 9.  A systematic review of four injection therapies for lateral epicondylosis: prolotherapy, polidocanol, whole blood and platelet-rich plasma.

Authors:  D Rabago; T M Best; A E Zgierska; E Zeisig; M Ryan; D Crane
Journal:  Br J Sports Med       Date:  2008-11-21       Impact factor: 13.800

10.  Outcomes of prolotherapy for intra-tendinous Achilles tears: a case series.

Authors:  Otto Chan; Ben Havard; Sarah Morton; Mel Pritchard; Nicola Maffulli; Tom Crisp; Nat Padhiar; Jeremy David Perry; John King; Dylan Morrissey
Journal:  Muscles Ligaments Tendons J       Date:  2017-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.